Amyloid beta oligomers induce impairment of neuronal insulin receptors

Zhao, Wei‐Qin, De Felice, Fernanda G., Fernandez, Sara, Chen, Hui, Lambert, Mary P., Quon, Michael J., Krafft, Grant A., Klein, William L.·2008·The FASEB Journal

Cited by (590)

Items 401–500 of 590

  1. Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia
    Hiroyuki Umegaki · 2016 · Drugs & Aging
  2. Icariin Attenuates Amyloid-β (Aβ)-Induced Neuronal Insulin Resistance Through PTEN Downregulation
    Xiaomei Zou, Xiyao Feng, Yalin Fu, Yuyang Zheng, Mingke Ma, Changhua Wang, Yemin Zhang · 2020 · Frontiers in Pharmacology
  3. Fe–oxy adducts of heme–Aβ and heme–hIAPP complexes: intermediates in ROS generation
    Manas Seal, Soumya Mukherjee, Somdatta Ghosh Dey · 2016 · Metallomics
  4. Pioglitazone use increases risk of Alzheimer's disease in patients with type 2 diabetes receiving insulin
    Hsin‐Chung Lin, Chi‐Hsiang Chung, Lih‐Chyang Chen, Jui‐Yang Wang, Chien‐Chou Chen, Kuo‐Yang Huang, Ming-Hang Tsai, Wu‐Chien Chien, Hsin‐An Lin · 2023 · Scientific Reports
  5. Nose-to-Brain Delivery of Peptide Drugs Enhanced by Coadministration of Cell-penetrating Peptides: Therapeutic Potential for Dementia
    Noriyasu Kamei · 2017 · YAKUGAKU ZASSHI
  6. Differential Binding of Human ApoE Isoforms to Insulin Receptor is Associated with Aberrant Insulin Signaling in AD Brain Samples
    Elizabeth S. Chan, Christopher Chen, Tuck Wah Soong, Boon‐Seng Wong · 2018 · NeuroMolecular Medicine
  7. Impaired insulin sensitivity is associated with worsening cognition in HIV-infected patients
    Saja S. Khuder, Suming Chen, Scott Lee Letendre, Thomas D. Marcotte, Igor Grant, Donald R Franklin, Leah H. Rubin, Joseph B. Margolick, Lisa P. Jacobson, Ned C Sacktor et al. · 2019 · Neurology
  8. Soy flavonoids prevent cognitive deficits induced by intra-gastrointestinal administration of beta-amyloid
    Julia Y.H. Liu, Michelle Y.Y. Sun, Nerina R. Sommerville, Man Piu Ngan, Eugene D. Ponomarev, Ge Lin, John Anthony Rudd · 2020 · Food and Chemical Toxicology
  9. Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain Cohort
    Annabelle Chambers, Joanna J. Bury, Thaı́s Minett, Connor Duncan Richardson, Carol Brayne, Paul G. Ince, Pamela J. Shaw, Claire J. Garwood, Paul Roy Heath, Julie E. Simpson et al. · 2020 · Journal of Neuropathology & Experimental Neurology
  10. Design, Synthesis, and Preliminary Evaluation of [68Ga]Ga-NOTA-Insulin as a PET Probe in an Alzheimer’s Disease Mouse Model
    Jillissa Taubel, Nicholas R. Nelson, Aditya Bansal, Geoffrey L. Curran, Lushan Wang, Zengtao Wang, Heather M. Berg, Cynthia J. Vernon, Hoon-Ki Paul Min, Nicholas Bradley Larson et al. · 2022 · Bioconjugate Chemistry
  11. Glucose enrichment impair neurotransmission and induce Aβ oligomerization that cannot be reversed by manipulating O-β-GlcNAcylation in the C. elegans model of Alzheimer's disease
    Waqar Ahmad · 2022 · The Journal of Nutritional Biochemistry
  12. Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights
    Sarvin Sanaie, Saba Nikanfar, Zahra Yousefi, Akbar Azizi-Zeinalhajlou, Saeed Sadigh‐Eteghad, Mostafa Araj‐Khodaei, Mohammad Hossein Ayati, Sasan Andalib · 2022 · Metabolic Brain Disease
  13. From Small Peptides to Large Proteins against Alzheimer’sDisease
    Pasquale Picone, Tiziana Sanfilippo, Sonya Vasto, Sara Baldassano, Rossella Guggino, Domenico Nuzzo, Donatella Bulone, Pier Luigi San Biagio, Emanuela Muscolino, Roberto Monastero et al. · 2022 · Biomolecules
  14. Cellular response to β‐amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics
    Haolin Zhang, Xianghua Li, Xiaoli Wang, Jiayu Xu, Felice Elefant, Juan Wang · 2023 · Animal Models and Experimental Medicine
  15. Does wine prevent dementia?
    Roger M. Pinder · 2009 · International Journal of Wine Research
  16. Intrahippocampal administration of a domain antibody that binds aggregated amyloid-β reverses cognitive deficits produced by diet-induced obesity
    Danielle M. Osborne, Dennis P. Fitzgerald, Kelsey E. O’Leary, Brian M. Anderson, Christine C. Lee, Peter M. Tessier, Ewan C. McNay · 2016 · Biochimica et Biophysica Acta (BBA) - General Subjects
  17. Phosphoinositide 3-kinase inhibitor AS605240 ameliorates streptozotocin-induced Alzheimer’s disease like sporadic dementia in experimental rats
    Ramesh Alluri, Sivamallikarjuna Reddy Ambati, Kasiviswanth Routhu, Spandana Rajendra Kopalli, Sushruta Koppula · 2019 · EXCLI journal
  18. Worming our way to novel drug discovery with the Caenorhabditis elegans proteostasis network, stress response and insulin-signaling pathways
    Linda P. O’Reilly, Joshua A. Benson, Erin E. Cummings, David H. Perlmutter, Gary A. Silverman, Stephen C. Pak · 2014 · Expert Opinion on Drug Discovery
  19. GLP-1 analogue CJC-1131 prevents amyloid β protein-induced impirments of spatial memory and synaptic plasticity in rats
    Sheng‐Xiao Zhang, Hong-Yan Cai, Xiaowen Ma, Yuan Li, Jun Zhang, Zhao‐Jun Wang, Yufeng Li, Jin‐Shun Qi · 2017 · Behavioural Brain Research
  20. Physiological Mechanisms Inherent to Diabetes Involved in the Development of Dementia: Alzheimer’s Disease
    Himan Mohamed-Mohamed, Victoria García‐Morales, Encarnacion Sanchez-Lara, Anabel González‐Acedo, Teresa Pardo-Moreno, María Isabel Tovar-Gálvez, Lucía Melguizo‐Rodríguez, Juan José Ramos‐Rodríguez · 2023 · Neurology International
  21. Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance
    Caihong Zhu, Petra Schwarz, Irina Abakumova, Adriano Aguzzi · 2015 · PLoS ONE
  22. Insulin and disorders of behavioural flexibility
    Mairéad Sullivan, Fernando Fernández‐Aranda, Lucía Camacho‐Barcia, Andrew Harkin, Simone Macrı̀, Bernat Mora‐Maltas, Susana Jiménez‐Múrcia, Aet O’Leary, Angela Maria Ottomana, Martina Presta et al. · 2023 · Neuroscience & Biobehavioral Reviews
  23. Functional Amyloids and their Possible Influence on Alzheimer Disease
    Angus Lau, Matthew E.C. Bourkas, Yang Qing Qin Lu, Lauren Ostrowski, Danielle Weber‐Adrian, Carlyn Figueiredo, Hamza Arshad, Seyedeh Zahra Shams Shoaei, Christopher Daniel Morrone, Stuart A Matan‐Lithwick et al. · 2017 · Discoveries
  24. Role of the SNK‐SPAR pathway in the development of Alzheimer's disease
    Xiaoyang Gong, Xiao-guang Lu, Libin Zhan, Hua Xiu Sui, Xin Qi, JI Zheng-hong, Xinping Niu, Li Liu · 2010 · IUBMB Life
  25. Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance
    Rabab Al‐Lahham, Nicolás Méndez · 2023 · Journal of Alzheimer s Disease
  26. Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies
    Jie Cai, Danni Xie, Fanjing Kong, Zhenwei Zhai, Zhishan Zhu, Yanru Zhao, Ying Xu, Tao Sun · 2024 · Journal of Alzheimer s Disease
  27. Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin
    Andrew L. Zhou, Nidhi Sharda, Vidur Sarma, Kristen M. Ahlschwede, Geoffry L. Curran, Xiaojia Tang, Joseph F. Poduslo, Krishna R. Kalari, Val J. Lowe, Karunya K. Kandimalla · 2021 · Journal of Alzheimer s Disease
  28. Low Density Lipoprotein Receptor-related Protein 2 Expression and Function in Cultured Astrocytes and Microglia
    Katsura Takano-Kawabe, Kazuyuki Matoba, Yoichi Nakamura, Mitsuaki Moriyama · 2023 · Neurochemical Research
  29. Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting
    Karin E. Sandoval, KEN A. WITT · 2024 · Pharmacological Reviews
  30. Disrupted mitochondrial response to nutrients is a presymptomatic event in the cortex of the APPSAA knock‐in mouse model of Alzheimer's disease
    Andrés Norambuena, Vijay Kumar Sagar, Zhuoying Wang, Prakash Raut, Ziang Feng, Horst Wallrabe, Evelyn Pardo, Taylor Kim, Shagufta Rehman Alam, Song Hu et al. · 2024 · Alzheimer s & Dementia
  31. Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond
    Océane Perdaens, Vincent Van Pesch · 2024 · International Journal of Molecular Sciences
  32. Insulin, Brain, Alzheimer’s Disease: New Evidence
    Svetlana Viktorovna Bulgakova, Романчук Петр Иванович, E. V. Treneva · 2020 · Bulletin of Science and Practice
  33. Cytotoxicity and Effects on the Synapsis Induced by Pure Cylindrospermopsin in an E17 Embryonic Murine Primary Neuronal Culture in a Concentration- and Time-Dependent Manner
    M.G. Hinojosa, Ana Isabel Prieto, Clara Muñoz‐Castro, Maria Virtudes Sanchez-Mico, Javier Vitórica, Ana Maria Cameán, Angeles M. Jos · 2022 · Toxins
  34. Effect and Mechanism of Exogenous Melatonin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis
    Zhenwei Zhai, Danni Xie, Tao Qin, Yanmei Zhong, Ying Xu, Tao Sun · 2022 · Neuroscience
  35. Antidepressants Modulate Intracellular Amyloid Peptide Species in N2a Neuroblastoma Cells
    Marwa A. Aboukhatwa, Yuan Luo · 2011 · Journal of Alzheimer s Disease
  36. Effect of Qingxin Kaiqiao Fang on Hippocampus mRNA Expression of the Inflammation‐Related Genes IL‐1β, GFAP, and Aβ in an Alzheimer’s Disease Rat Model
    Dan-Dan Mao, Wenyu Yang, Yan Li, Jianwei Lin, Shiyu Gao, Yiru Wang, Haiyan Hu · 2018 · Evidence-based Complementary and Alternative Medicine
  37. Suppression of neuronal cholesterol biosynthesis impairs brain functions through insulin-like growth factor I-Akt signaling
    Ting Liu, Yang Li, Baoyu Yang, Haozhen Wang, Lu Chen, Alan K. Chang, Xiuting Huang, Xiujin Zhang, Ziyin Lu, Xiuli Lu et al. · 2021 · International Journal of Biological Sciences
  38. Dementia in diabetes mellitus and atherosclerosis: Two interrelated systemic diseases
    Parvaneh Mohseni Moghaddam, Roshanak Ghobadian, Hossein Khaleghzadeh‐Ahangar · 2022 · Brain Research Bulletin
  39. Gain of function by phosphorylation in Presenilin 1‐mediated regulation of insulin signaling
    Masato Maesako, Kengo Uemura, Akira Kuzuya, Kazuki Sasaki, Megumi Asada, Kiwamu Watanabe, Koichi Andō, Masakazu Kubota, Haruhiko Akiyama, Ryōsuke Takahashi et al. · 2012 · Journal of Neurochemistry
  40. Insulin regulates Presenilin 1 localization via PI3K/Akt signaling
    Masato Maesako, Kengo Uemura, Masakazu Kubota, Koichi Ando, Akira Kuzuya, Megumi Asada, Takeshi Kihara, Ayae Kinoshita · 2010 · Neuroscience Letters
  41. Protective Effects of Bexarotene against Amyloid-β25-35-Induced Dysfunction in Hippocampal Neurons through the Insulin Signaling Pathway
    Weiwei Dai, Jiajia Yang, Ting Chen, Zhuo Ru Yang · 2014 · Neurodegenerative Diseases
  42. Increased expression and local accumulation of the Prion Protein, Alzheimer Aβ peptides, superoxide dismutase 1, and Nitric oxide synthases 1 & 2 in muscle in a rabbit model of diabetes
    Claudine L. Bitel, Yicheng Feng, Nizar Souayah, Peter H. Frederikse · 2010 · BMC Physiology
  43. A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro
    Querfurth, Henry, Marshall, John, Parang, Keykavous, Rioult-Pedotti, Mengia S., Tiwari, Rakesh, Kwon, Bumsup, Reisinger, Steve, Lee, Han-Kyu · 2022 · PLOS ONE
  44. Temporal and Regional Expression of Glucose-Dependent Insulinotropic Peptide and Its Receptor in Spinal Cord Injured Rats
    Ana Beatriz Sperb Wanderley Marcos, Stefânia Forner, Alessandra Cadete Martini, Eliziane de Souza Patrício, Julia Rosauro Clarke, Robson da Costa, João Felix-Alves, Vilberto José Vieira, Edinéia Lemos de Andrade, Tânia Longo Mazzuco et al. · 2015 · Journal of Neurotrauma
  45. Insulin signaling as a therapeutic target in Alzheimer’s disease: Efficacy of apomorphine
    Yasumasa Ohyagi, Satoko Takei · 2020 · Neurology and Clinical Neuroscience
  46. Possible Clues for Brain Energy Translation via Endolysosomal Trafficking of APP‐CTFs in Alzheimer’s Disease
    Senthilkumar Sivanesan, Ravi Mundugaru, Jayakumar Rajadas · 2018 · Oxidative Medicine and Cellular Longevity
  47. Beta-amyloid oligomers: recent developments
    Borutaite, Vilmante, Morkuniene, Ramune, Valincius, Gintaras · 2011 · bmc
  48. Brain insulin resistance in Down syndrome: Involvement of PI3K-Akt/mTOR axis in early-onset of Alzheimer's disease and its potential as a therapeutic target
    Mansour Azimzadeh, Pike-See Cheah, King‐Hwa Ling · 2024 · Biochemical and Biophysical Research Communications
  49. Impacts of glutamate, an exercise-responsive metabolite on insulin signaling
    Xiaorui Xing, Qin Sun, Ruwen Wang, Ru Wang, Ru Wang · 2024 · Life Sciences
  50. Derailed Intraneuronal Signalling Drives Pathogenesis in Sporadic and Familial Alzheimer’s Disease
    Tom Van Dooren, Katrien Princen, Koen De Witte, Gerard Griffioen · 2014 · BioMed Research International
  51. The effect of insulin receptor deletion in neuropeptide Y neurons on hippocampal dependent cognitive function in aging mice
    Elisabeth K. Goodman, Caitlin S. Mitchell, Jonathan D. Teo, Joanne M. Gladding, Kirsten N. Abbott, Neda Rafiei, Lei Zhang, Herbert Herzog, Denovan P. Begg · 2022 · Journal of Integrative Neuroscience
  52. ‘Type 3 diabetes’: linking a brain insulin‐resistant state with dementia and Alzheimer's disease
    Ken Shaw · 2013 · Practical Diabetes
  53. Effect of Qingxinkaiqiao compound on cortical mRNA expression of the apoptosis-related genes Bcl-2, BAX, caspase-3, and Aβ in an Alzheimer's disease rat model
    Haiyan Hu, Wang Yiyu, Zhang Yihui, Wang Wenhua, Dongmei Xu, Chen Zhiyu, Zhang Xiaoyan, Mao Dandan · 2016 · 中医杂志:英文版
  54. The Gut Microflora and its Metabolites Regulate the Molecular Crosstalk between Diabetes and Neurodegeneration
    Susan Westfall Nikita Lomis · 2015 · Journal of Diabetes & Metabolism
  55. Examining the effects of ovarian hormone loss and diet-induced obesity on Alzheimer’s disease markers of amyloid-β production and degradation
    Grant C. Hayward, Bradley J. Baranowski, Daniel M. Marko, Rebecca E. K. MacPherson · 2021 · Journal of Neurophysiology
  56. The Interplay Between Cholesterol and Amyloid-β on HT22 Cell Viability, Morphology, and Receptor Tyrosine Kinase Signaling
    Morgan J. Robinson, Sean Newbury, Kartar Singh, Zoya Leonenko, Michael A. Beazely · 2023 · Journal of Alzheimer s Disease
  57. The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s Disease
    Kiran Bhaskar, Bruce T. Lamb · 2011 · Springer eBooks
  58. Tau, Diabetes and Insulin
    Maud Gratuze, Aurélie Joly‐Amado, Luc Buée, Didier Vieau, David L Blum · 2019 · Advances in experimental medicine and biology
  59. The role of type 2 Diabetes mellitus as a risk factor for Alzheimer's and Parkinson's diseases
    Kellen Mariane Athaide Rocha, Aline da Silva Goulart, Márcio Tavares Costa, Andréia Caroline Fernandes Salgueiro, Vanderlei Folmer · 2021 · Research Society and Development
  60. The mTOR Signaling Pathway in Neurodegenerative Diseases
    Arnaud Francois, Julie Vérité, Agnès Rioux Bilan, Thierry Janet, Frédéric Calon, Bernard Fauconneau, Marc Paccalin, Guylène Page · 2016 · Elsevier eBooks
  61. Early divergent modulation of NLRP2′s and NLRP3′s inflammasome sensors vs. AIM2′s one by signals from Aβ·Calcium-sensing receptor complexes in human astrocytes
    Anna Chiarini, Ubaldo Armato, Li Gui, Meifang Yin, Shusen Chang, Ilaria Dal Prà · 2024 · Brain Research
  62. Investigation of Cyclo-Z Therapeutic Effect on Insulin Pathway in Alzheimer's Rat Model: Biochemical and Electrophysiological Parameters
    Alev Duygu Acun, Deniz Kantar, Hakan Er, Orhan Erkan, Narin Derin, Piraye Yargıçoğlu · 2023 · Molecular Neurobiology
  63. Development of a Cellular Tau Enzyme-Linked Immunosorbent Assay Method for Screening GSK-3β Inhibitors
    Goang‐Won Cho, Min‐Young Noh, Byung Yong Kang, Il-Whea Ku, Ji‐Seon Park, Yoon‐Ho Hong, Myung‐Hwa Kim, Seung Hyun Kim · 2011 · Assay and Drug Development Technologies
  64. Why Alzheimer’s is a Disease of Memory: Synaptic Targeting by Pathogenic Aβ Oligomers (ADDLs)
    William L. Klein, Fernanda G. De Felice, Pascale N. Lacor, Mary P. Lambert, Wei-Qin Zhao · 2008 · Research and perspectives in Alzheimer's disease
  65. Modulation of the microbiota-gut-brain axis by bioactive food, prebiotics, and probiotics decelerates the course of Alzheimer's disease
    Daniel Cuervo-Zanatta, Brenda Pérez-Grijalva, Esael González-Magaña, Julieta Hernández-Acosta, Selvasankar Murugesan, Jaime Garcı́a-Mena, Claudia Perez‐Cruz · 2021 · Studies in natural products chemistry
  66. Effects of insulin and amyloid β1–42 oligomers on glucose incorporation and mitochondrial function in cultured rat hippocampal neurons
    Yoshiaki Miichi, Takashi Sakurai, Taichi Akisaki, Koichi Yokono · 2011 · Geriatrics and gerontology international/Geriatrics & gerontology international
  67. Physiopathological Roles of White Adiposity and Gut Functions in Neuroinflammation
    Eduardo Spinedi, Guillermo Horacio Docena · 2024 · International Journal of Molecular Sciences
  68. Ginsenoside CK modulates glucose metabolism via PPARγ to ameliorate SCOP-induced cognitive dysfunction
    Na Li, Xingyu Fang, Hui Li, Jian Liu, Nan Chen, Xiaohui Zhao, Qing Yang, Xijun Chen · 2025 · Metabolic Brain Disease
  69. High Risk of Metabolic Complications Due to High Consumption of Processed Foods
    Chitra Vellapandian, Ankul Singh · 2022 · Current Nutrition & Food Science
  70. Mind the Metabolic Gap: Bridging Migraine and Alzheimer's disease through Brain Insulin Resistance
    Lorenzo Del Moro, Elenamaria Pirovano, Eugenia Rota · 2024 · Aging and Disease
  71. Disruption of Endoplasmic Reticulum Proteostasis in Age-Related Nervous System Disorders
    Danilo B. Medinas, Younis Hazari, Claudio A. Hetz · 2021 · Progress in molecular and subcellular biology
  72. Aβ Oligomers-Induced Toxicity is Attenuated in Cells Cultured with NbActiv4™ Medium
    Yan Zhou, William L. Klein · 2012 · Neurotoxicity Research
  73. Insights into the mechanism of Alzheimer’s β-amyloid aggregation as a function of concentration by using atomic force microscopy
    Gina-Mirela Mustata, Gajendra S. Shekhawat, Mary P. Lambert, Kirsten L. Viola, Pauline T. Velasco, William L. Klein, Vinayak P. Dravid · 2012 · Applied Physics Letters
  74. Type II Diabetes Mellitus Accelerates Age-Dependent Aβ Pathology in Cynomolgus Monkey Brain
    Nobuyuki Kimura · 2019 · Advances in experimental medicine and biology
  75. The role of peripheral β-amyloid in insulin resistance, insulin secretion, and prediabetes: in vitro and population-based studies
    Zihui Xu, Juan Chen, Pei Wang, Linyan Li, Shan Hu, Hongjie Liu, Yue Huang, Xiaoxing Mo, Hong Yan, Zhilei Shan et al. · 2023 · Frontiers in Endocrinology
  76. Alzheimer’s Disease and Diabetes
    David A. Brent, Gary L., Zaid Aboud, Gordon W. · 2013 · InTech eBooks
  77. The Pathogenesis Mechanism, Structure Properties, Potential Drugs and Therapeutic Nanoparticles against the Small Oligomers of Amyloid-β
    Ke Wang, Liu Na, Mojie Duan · 2020 · Current Topics in Medicinal Chemistry
  78. Beer as an Integral Part of Healthy Diets: Current Knowledge and Perspective
    Ida Leskošek-Čukalović · 2015 · Food engineering series
  79. Insulin Receptors and Intracellular Ca2+ Form a Double-Negative Regulatory Feedback Loop Controlling Insulin Sensitivity
    Помыткин Игорь Анатольевич, Vsevolod G. Pinelis · 2021 · F1000Research
  80. Drugs and Drug Delivery Systems Targeting Amyloid-\b{eta} in Alzheimers Disease
    Morgan J. Robinson, Brenda Yasie Lee, Zoya Leonenko · 2017 · arXiv (Cornell University)
  81. Exercise Suppresses Insulin Resistance: A Potential Mechanism for Improving the Interaction Between Type 2 Diabetes and Alzheimer’s Disease
    Bo Wang, Yuping Shao, Rongxiang Liang · 2026 · Journal of Integrative Neuroscience
  82. Pathophysiological mechanism and natural preventive and therapeutic strategies of Alzheimer's disease
    Abdelkader Basli, Jihane Bounaas · 2022 · Nutrition and Health
  83. Association of individual-based morphological brain network alterations with cognitive impairment in type 2 diabetes mellitus
    Die Shen, Xuan Huang, Ziyu Diao, Jiahe Wang, Kun Wang, Weiye Lu, Shijun Qiu · 2025 · Frontiers in Neurology
  84. Type 2 Diabetes, Obesity, and Risk for Dementia: Recent Insights into Brain Insulin Resistance and Hypometabolism
    Christina E. Hugenschmidt · 2016 · Current Behavioral Neuroscience Reports
  85. Cognitive Function in Offspring of Mothers with Gestational Diabetes–The Role of Insulin receptor
    Hossein Haghir · 2016 · MOJ Anatomy & Physiology
  86. Diabetes and Alzheimer’s Disease
    Shuko Takeda, Ryuichi Morishita · 2017 · Springer eBooks
  87. NEUROINFLAMMATION AND INSULIN RESISTANCE IN ALZHEIMER’S DISEASE
    Yana V. Gorina, Alla Borisovna Salmina, Natalia V. Kuvacheva, Yulia K. Komleva, Lyudmila V. Fedyukovich, Yu. A. Uspenskaya, Г. А. Морозова, Ирина Владимировна Демко, Марина Михайловна Петрова · 2014 · Siberian medical review
  88. Insulin Receptors and Intracellular Ca2+ Form a Double-Negative Regulatory Feedback Loop Controlling Insulin Sensitivity
    Помыткин Игорь Анатольевич, Vsevolod G. Pinelis · 2020 · F1000Research
  89. Genetic Association between Akt1 Polymorphisms and Alzheimer′s Disease in a Japanese Population
    Nobuto Shibata, Tohru Ohnuma, Bolati Kuerban, Miwa Komatsu, Hajime Baba, Heii Arai · 2011 · International Journal of Alzheimer s Disease
  90. Metabolic Syndrome as a Risk Factor for Alzheimer Disease
    A. A. Farooqui · 2013 · Springer eBooks
  91. Brain Insulin Resistance: Focus on Insulin Receptor-Mitochondria Interactions
    Igor Pinelis, Vsevolod G. Pinelis · 2021 · Preprints.org
  92. Phytochemicals in Life Style Associated Human Diseases
    Harkomal Verma, Prabhakar Gangwar, Anuradha Yadav, Bharti Yadav, Rashmi Rao, Sakshi Kumari, Sharanjot Kaur, Monisha Dhiman, Anil Kumar Mantha · 2025 · Advances in Science, Technology & Innovation/Advances in science, technology & innovation
  93. BACE1 at the crossroads of a vicious circle between Alzheimer’s disease and diabetes mellitus
    Masuo Ohno · 2025 · Frontiers in Dementia
  94. PKC and Insulin Pathways in Memory Storage: Targets for Synaptogenesis, Anti-apoptosis, and the Treatment of AD
    Miao‐Kun Sun, Thomas J. Nelson, Daniel L. Alkon · 2010 · Research and perspectives in Alzheimer's disease
  95. The Effect of Zeolite Zinc on Memory Performance and Hippocampal Cell Death in a Rat Model of Alzheimer’s-like Disease Induced by Aβ1–42
    Maryam Zaman Fashami, Aida Bajelan, H.R. Shakur, Fatemeh Khakpai, Fatemeh Rouhollah, Salar Vaseghi, Batool Ghorbani Yekta · 2024 · Biological Trace Element Research
  96. Effect of boswellic acid in Alzheimer’s disease in experimental rat
    Mai M. El-Keiy, Menna Allah M. Youssef, Azza A. Bakry, Tarek Mostafa Mohamed · 2019 · Journal of Bioscience and Applied Research/Journal of Bioscience and Applied Research
  97. Alzheimer Disease and Metabolism: Role of Cholesterol and Membrane Fluidity
    Genaro G., P. Fermin, Luis J., Miguel A., E. Irma, A. Anguiano, Erandis D. Torres-Sánchez, W. Eddic, Jose A., E Genaro et al. · 2013 · InTech eBooks
  98. Depression, Diabetes and Dementia
    Joshua Daniel Rosenblat, Rodrigo Barbachan Mansur, Danielle S. Cha, Anusha Baskaran, Roger S. McIntyre · 2014 · Key issues in mental health (Online)/Key issues in mental health (Print)
  99. Insulin Resistance: A Bridge between T2DM and Alzheimer’s Disease
    Daniela Giacomazza, Marta Di Carlo · 2013 · Journal of Diabetes & Metabolism
  100. The expression of insulin-like growth factor-1 in senior patients with diabetes and dementia
    Yanling Zhou, Shuqing Liu, Bin Yuan, Ning Lü · 2016 · Experimental and Therapeutic Medicine